• Montagu Acquires Tyber Medical 

    by | Jan 15, 2025 3:53 pm | Medical Devices

    Montagu Private Equity announced on January 14 the acquisition of Tyber Medical for an undisclosed price. With this transaction, Montagu will merge Tyber Medical with its portfolio companies Intech and Resolve Surgical Technologies to create a new platform.   Tyber Medical is an orthopedic medical device manufacturer providing rapid... Read More »

  • Takara Bio USA Holdings Acquires Curio Bioscience 

    by | Jan 15, 2025 3:52 pm | Biotechnology

    On January 15, Takara Bio USA Holdings Inc., a wholly owned subsidiary of Takara Bio Inc., announced that it acquired Curio Bioscience.   Curio Bioscience is a biotechnology company that is advancing a new generation of high-precision tools for the life sciences industry. The company has developed spatial biology capabilities to map the... Read More »

  • 2025 Kicks off With Several Big Biopharma Deals

    by | Jan 15, 2025 10:25 am | Biotechnology, Pharmaceuticals

    With the JP Morgan 43rd Annual Healthcare Conference underway in San Francisco this week, the Biotechnology and Pharmaceutical (Biopharma) sectors are seeing a flurry of activity. Many large-scale acquisitions and licensing agreements are being announced, setting the tone for an eventful year ahead in the industry. So far this year, 14 Biopharma... Read More »

  • In Motion Physical Therapy Joins PE-Backed Ivy Rehab

    by | Jan 14, 2025 12:27 pm | Private Equity, Rehabilitation

    Private equity-backed Ivy Rehab announced in January 2025 that it has partnered with In Motion Physical Therapy in Downingtown, Pennsylvania. Financial terms of the deal were not disclosed.  In Motion Physical Therapy is a provider of outpatient physical therapy in Pennsylvania. The company is led by a team of therapists specializing in... Read More »

  • West Physics Consulting Acquires Mid-South Medical Physics in Arkansas

    by | Jan 14, 2025 12:25 pm | Other Services

    West Physics Consulting announced on January 13 that it has entered into a strategic partnership agreement with Mid-South Medical Physics. The partnership with Mid-South includes a multi-phase acquisition of Mid-South by West Physics, allowing Mid-South’s owner and President, Mr. Paul Beck, to gradually retire as West Physics supports him... Read More »

Prudential Real Estate Investors Buys 3 AL Properties

by | Jun 1, 2015 6:44 pm | Long-Term Care

Prudential Real Estate Investors (PREI)is a private real estate firm owned by Prudential Insurance, paid $110 million for three assisted living facilities, two of which are in Tennessee: Hendersonville, with 130 units built in 2012 and Franklin, with 126 units built in 2014. The Connecticut community is in Glastonbury with 135 units built in 2014. All three offer assisted living and memory care, and have a combined 341,000 square feet. Hearth Management, which previously owned the properties through a joint venture partnership, has been retained as the managery. Read More »

NorthStar Retires $640 Million to 15 CCRCs

by | Apr 20, 2015 4:03 pm | Long-Term Care

Fountains Senior Living Holdings LLC is selling 15 continuing care retirement communities (CCRCs) in 11 states. NorthStar Healthcare Income, Inc., a public, non-traded REIT, has plunked down $640 million for the portfolio, which consists of six entrance-fee and nine rental CCRCs, total 3,637 units. Watermark Retirement Communities will continue as the day-to-day operator of the CCRCs. The deal is expected to close around June 1, at which time NorthStar will lease the entrance fee properties to affiliates of The Freshwater Group Inc., pursuant to a master net lease. The rental properties will be held under a RIDEA structure, with NorthStar owning 97% and Freshwater owning 3%. Read More »

Another Record Falls in Q1:15

by | Apr 4, 2015 3:19 pm | Behavioral Health Care, Biotechnology, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

Now that the month is officially over, we can report our preliminary Q1:15 results—and it was another record breaker, at least for transactions. The 346 deals logged so far are 109% higher than the first quarter of 2014. You would think that the $104.7 billion in combined spending would set another record, but no. In Q1:09, we tracked $127.2 billion spent on 202 deals. That’s when Pfizer (NYSE: PFE) bought Wyeth for $68 billion.  Here’s the preliminary breakdown of Q1:15 — and remember, the spending is only for deals that disclosed prices. Read More »